BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27812168)

  • 1. Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis.
    Zhang Z; Luo G; Tang H; Cheng C; Wang P
    PLoS One; 2016; 11(11):e0165725. PubMed ID: 27812168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of β-catenin Expression in Breast Cancer Patients: a Meta-analysis.
    Zhang DP; Li XW; Lang JH
    Asian Pac J Cancer Prev; 2015; 16(14):5625-33. PubMed ID: 26320427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis.
    Chen Y; Wang X; Chen G; Dong C; Zhang D
    PLoS One; 2015; 10(3):e0121404. PubMed ID: 25816052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of tissue vascular endothelial growth factor expression in bladder cancer: a meta-analysis.
    Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
    Asian Pac J Cancer Prev; 2013; 14(2):645-9. PubMed ID: 23621212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.
    Peng L; Zhan P; Zhou Y; Fang W; Zhao P; Zheng Y; Xu N
    Mol Biol Rep; 2012 Oct; 39(10):9473-84. PubMed ID: 22729879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.
    Wang J; Guo Y; Wang B; Bi J; Li K; Liang X; Chu H; Jiang H
    Mol Biol Rep; 2012 Dec; 39(12):11153-65. PubMed ID: 23054001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis.
    Song J; Su H; Zhou YY; Guo LL
    Asian Pac J Cancer Prev; 2013; 14(3):1615-21. PubMed ID: 23679245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of vascular endothelial growth factor expression in patients with prostate cancer: a systematic review with meta-analysis.
    Wang K; Peng HL; Li LK
    Asian Pac J Cancer Prev; 2012; 13(11):5665-9. PubMed ID: 23317235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
    Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
    Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of microRNA-101 in solid tumor: A meta-analysis.
    Ma X; Bai J; Xie G; Liu Y; Shuai X; Tao K
    PLoS One; 2017; 12(7):e0180173. PubMed ID: 28742860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic implication of slug in all tumour patients - a systematic meta-analysis.
    Huang C; Zhang P; Zhang D; Weng X
    Eur J Clin Invest; 2016 May; 46(5):398-407. PubMed ID: 26919035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis.
    Xu TP; Shen H; Liu LX; Shu YQ
    Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCNB2 expression correlates with worse outcomes in breast cancer patients: a pooled analysis.
    Sun C; Lowe S; Ma S; Bentley R; Zhou Z; Cheng C; Zhou Q
    Women Health; 2022 Aug; 62(7):655-663. PubMed ID: 35892137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of survivin in breast cancer: meta-analysis.
    Li Y; Ma X; Wu X; Liu X; Liu L
    Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis.
    Tan G; Chu C; Gui X; Li J; Chen Q
    Medicine (Baltimore); 2018 Mar; 97(13):e0197. PubMed ID: 29595655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive role of the overexpression for CXCR4, C-Met, and VEGF-C among breast cancer patients: A meta-analysis.
    Wang F; Li S; Zhao Y; Yang K; Chen M; Niu H; Yang J; Luo Y; Tang W; Sheng M
    Breast; 2016 Aug; 28():45-53. PubMed ID: 27214240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
    Xia Y; Wei X; Gong H; Ni Y
    BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of the let-7 family in various carcinomas: A meta-analysis update.
    Zhang CL; Li Z; Liu YP; Wu Y; Qu XJ
    J BUON; 2015; 20(2):631-44. PubMed ID: 26011360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.